Article
The Current State of Biomarker Research for Friedreich’s Ataxia: A Report From the 2018 FARA Biomarker Meeting
28 Jun 2019
Abstract excerpt
The 2018 FARA Biomarker Meeting highlighted the current state of development of biomarkers for Friedreich's ataxia. A mass spectroscopy assay to sensitively measure mature frataxin (reduction of which is the root cause of disease) is being developed. Biomarkers to monitor neurological disease progression include imaging, electrophysiological measures and measures of nerve function, which may be measured either in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
